Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.

NCT ID: NCT00632125

Last Updated: 2017-07-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

1695 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cumulative follow-up with HX575 epoetin alfa to prospectively monitor the incidence of relevant drug-related adverse events and EPO-related lack of efficacy among Chronic Kidney Disease (CKD) subjects receiving HX575 epoetin alfa i.v.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was a multi-center, multinational, prospective, single-arm clinical study with a 6-month treatment period. The primary objective was to extend the safety database of patients with CKD who receive i.v. HX575 epoetin alfa treatment and to monitor the adverse event (AE) profile under post-approval conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HX575 epoetin alfa i.v.

This post-authorization safety study was designed as a multi-center, multinational, prospective, single-arm clinical study with a 6-month HX575 (recombinant human) erythropoietin alfa treatment period. It was planned to include approximately 1,500 patients.

Group Type EXPERIMENTAL

HX575 recombinant human erythropoietin alfa

Intervention Type DRUG

HX575 epoetin alfa i.v. will be administered according to the SmPC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HX575 recombinant human erythropoietin alfa

HX575 epoetin alfa i.v. will be administered according to the SmPC

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HX575 epoetin alfa

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CKD subjects with or without dialysis treatment
* Age over 18 years
* Subjects requiring i.v. ESA treatment
* Subjects likely to remain on i.v. ESA treatment for 6 months
* Provision of informed consent -

Exclusion Criteria

* Systemic immunosuppressive medication or any other drugs known to adversely affect the hemoglobin level
* Known primary lack of efficacy (LOE), unexplained loss of effect to a recombinant erythropoietin product
* History of PRCA or aplastic anemia
* History of anti-erythropoietin antibodies
* Uncontrolled hypertension
* Pregnant woman or nursing mother
* Women of childbearing potential do not agree to maintain effective birth control during the study treatment period.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hexal AG

INDUSTRY

Sponsor Role collaborator

Sandoz

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karsten Roth, Dr

Role: STUDY_CHAIR

Hexal AG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nierenzentrum Prenzlau

Prenzlau, , Germany

Site Status

Nephrologische Ambulanz/ Dialyse

Singen, , Germany

Site Status

Dialysepraxis Dres. Huspek/Schmid

Bad Ischl, , Austria

Site Status

Landeskrankenhaus Feldkirch

Feldkirch, , Austria

Site Status

Landeskrankenhaus Freistadt

Freistadt, , Austria

Site Status

LKH Rohrbach

Rohrbach, , Austria

Site Status

Universitätsklinik für Innere Medizin III

Vienna, , Austria

Site Status

Multiprofile Hospital for Active Treatment Dr. Tota Venkova

Gabrovo, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment Dr. Kiro Popov

Karlovo, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment Pazardzhik

Pazardzhik, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment Rousse

Rousse, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment Sv. Ivan Rilski

Sofia, , Bulgaria

Site Status

Ministry of Interior-Central Clinical Base

Sofia, , Bulgaria

Site Status

CHG Hopital Yves le Foll

Saint-Brieuc, , France

Site Status

Fachpraxis für Nieren und Hochdruckerkrankungen

Andernach, , Germany

Site Status

KfH Kuratorium für Nierentranplantation und Dialyse e.V.

Aschaffenburg, , Germany

Site Status

Gemeinschaftspraxis

Baunatal, , Germany

Site Status

Kuratorium ür Dialyse und Nierentransplantation e.V.

Bayreuth, , Germany

Site Status

KfH Nierenzentrum

Berlin, , Germany

Site Status

Alwall Praxis für Nieren- und Hochdruckkrankheiten

Berlin, , Germany

Site Status

Dialysepraxis

Bremerhaven, , Germany

Site Status

Dialysepraxis Drs. Riedasch/Schreiber

Coesfeld, , Germany

Site Status

KfH Nierenzentrum

Cologne, , Germany

Site Status

Facharzt für Innere Medizin und Nephrologie, Dialyse Centrum

Darmstadt, , Germany

Site Status

KfH Kuratorium für Nierentranplantation und Dialyse e.V.

Deggendorf, , Germany

Site Status

Dialysezentrum

Dinkelsbühl, , Germany

Site Status

Diabetes- und Dialysezentrum Merker, Vogt

Dormagen, , Germany

Site Status

KfH Nierenzentrum

Dortmund, , Germany

Site Status

Gemeinschaftspraxis Karlstraße

Düsseldorf, , Germany

Site Status

Kuratorium für Dialyse und Nierentransplantation e.V.

Ehingen, , Germany

Site Status

Dialysezentrum Elsenfeld

Elsenfeld, , Germany

Site Status

Gemeinschaftspraxis Dr. Spitthöver, Dr. Knee, Dr. Gröschel

Essen, , Germany

Site Status

KfH Kuratorium für Dialyse und Nierentransplantation e.V.

Essen, , Germany

Site Status

Dialysezentrum

Freiburg im Breisgau, , Germany

Site Status

KfH Kuratorium für Dialyse und Nierentransplantation e.V

Fürstenzell, , Germany

Site Status

KfH Kuratorium für Dialyse und Nierentransplantation e.V

Gummersbach, , Germany

Site Status

Dialyse Hamburg Barmbek

Hamburg, , Germany

Site Status

Dialysepraxis Dr. Spengler

Helmstedt, , Germany

Site Status

Marienhospital Herne

Herne, , Germany

Site Status

Dialyse-Zentrum Elsterland

Herzberg, , Germany

Site Status

Praxis Dr. Menzer

Homberg (Efze), , Germany

Site Status

Nephrologische Praxis

Höchstadt an der Aisch, , Germany

Site Status

Gemeinschaftspraxis

Kamp-Lintfort, , Germany

Site Status

Dialysepraxis

Lahr, , Germany

Site Status

Praxis für Innere Medizin und Nephrologie

Leverkusen, , Germany

Site Status

Nephrologisches Zentrum Emsland

Lingen, , Germany

Site Status

Dialysezentrum und Schwerpunktpraxis für Nieren- und Hochdruckerkrankungen

Mannheim, , Germany

Site Status

Gemeinschaftspraxis

Mayen, , Germany

Site Status

Nephrologisches Zentrum Mettmann

Mettmann, , Germany

Site Status

KfH Kuratorium für Nierentranplantation und Dialyse e.V.

Oberschleißheim, , Germany

Site Status

KfH Kuratorium für Dialyse und Nierentransplantation e.V

Straubing, , Germany

Site Status

Nieren- und Diabeteszentrum Viersen-Nettetal

Viersen-Dülken, , Germany

Site Status

IRCCS INRCA Sede de Ancona

Ancona, , Italy

Site Status

Ospedali Riuniti di Anzio e Nettuno

Anzio, , Italy

Site Status

U.O.C. Nefrologia e Dialisi, C.G. Mazzoni

Ascoli Piceno, , Italy

Site Status

Ospedaliero Universitaria Policlinico S. Orsola Malpighi

Bologna, , Italy

Site Status

Azienda Ospdealiero "Istituti Ospitalieri"

Cremona, , Italy

Site Status

Ospedale E. Profili di Fabriano

Fabriano, , Italy

Site Status

AO Universitaria Ospedali Riuniti

Foggia, , Italy

Site Status

Universitaria Degli Studi di Genova Clinica Nefrologica, Dialisi e Trapianto

Genova, , Italy

Site Status

Ospedale A. Manzoni

Lecco, , Italy

Site Status

Azienda Ospedaliera Carlo Poma di Mantova

Mantova, , Italy

Site Status

Azienda Ospedaliera Ospedale San Carlo Borromeo

Milan, , Italy

Site Status

Azienda Ospedaliera Ospedale Niguarda Ca Granda

Milan, , Italy

Site Status

AO Universitaria di Modena

Modena, , Italy

Site Status

Ospedale Maggiore di Modica

Modica, , Italy

Site Status

U.O. Nefrologia e Dialisi, P.O. Ospedale Casati, Centro Dialisi

Passirana Di Rho, , Italy

Site Status

Fondazione S. Maugeri

Pavia, , Italy

Site Status

Azienda Ospedaliera ospedale S. Salvatore

Pesaro, , Italy

Site Status

Ospedale A. Landolfi

Solofra, , Italy

Site Status

Azienda Ospedaliera CTO - Maria Adelaide

Torino, , Italy

Site Status

Ospedale San Giovanni Bosco

Torino, , Italy

Site Status

Ospedale di Trento / Santa Chiara

Trento, , Italy

Site Status

Ospedale dell'Angelo

Venezia Mestre, , Italy

Site Status

PHO Clinical Hospital Dr. Trifun Panovski

Bitola, , North Macedonia

Site Status

PHO Health organisation Goce Delcev

Delcevo, , North Macedonia

Site Status

PHO General Hospital Kocani

Kočani, , North Macedonia

Site Status

PHO General Hospital Borka Taleski

Prilep, , North Macedonia

Site Status

PHO General Hospital Stip

Shtip, , North Macedonia

Site Status

PHO Clinic of Nephrology

Skopje, , North Macedonia

Site Status

Institute of Nephrology

Struga, , North Macedonia

Site Status

PHO Medical Center Veles

Veles, , North Macedonia

Site Status

Specjalistyczny Szpital Wojewodzki w Ciechanowie

Ciechanów, , Poland

Site Status

Wojewodzki Szpital Specjalistyczny im. Najswietszej maryi Panny

Częstochowa, , Poland

Site Status

Samodzielnym Publicznym Zakladzie Opieki Zdrowotnej Dzialdowo

Działdowo, , Poland

Site Status

Stacja Dializ w Garwolinie

Garwolin, , Poland

Site Status

Szpital Specjalistyczny Sw. W. Adalberta

Gdansk, , Poland

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej AVITUM

Golub-Dobrzyń, , Poland

Site Status

B. Braun AVITUM Poland Sp.

Legnica, , Poland

Site Status

SP Szpital Kliniczny im. Barlickiego

Lodz, , Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny nr 4

Lublin, , Poland

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej

Pabianice, , Poland

Site Status

Radomski Szpital Specjalistyszny im. Dr Tytusa Chalubinskiego

Radom, , Poland

Site Status

Wojewodzki Szpital Specjalistyczny nr 3

Rybnik, , Poland

Site Status

Szpital Bielanski Blok F

Warsaw, , Poland

Site Status

Centralny Szpital Kliniczny MSWiA

Warsaw, , Poland

Site Status

Szpital Powiatowy im. Lekarza Z. Koprowskiego

Warsaw, , Poland

Site Status

Spitalul Clinic Municipal

Arad, , Romania

Site Status

Institutul Clinic Fundeni

Bucharest, , Romania

Site Status

Spitalul Clinic de urgenta "Floreasca"

Bucharest, , Romania

Site Status

Spitalul Universitar de Urgenta

Bucharest, , Romania

Site Status

SC Renamed Nefrodial SRL

Oradea, , Romania

Site Status

FGUZ Clinical hospital No. 83 of FMBA of Russia

Moscow, , Russia

Site Status

City Clinal Hospital # 34

Novosibirsk, , Russia

Site Status

MLPU "Clinical City Hospital # 1"

Smolensk, , Russia

Site Status

GUZ "Yaroslavl regional clinical hospital"

Yaroslavl, , Russia

Site Status

Oblasna klinichna likarnia imeni I.I.Mechnikova

Dnipropetrovsk, , Ukraine

Site Status

Oblasnyi tsentr urologii ta nefrologii

Kharkiv, , Ukraine

Site Status

Tsentralnyi miskyi klinichnyi hospital, Viddilennia gemodializu

Kyiv, , Ukraine

Site Status

Miska klinichna likarnia#3, Miskyi nefrologichnyi tsentr

Kyiv, , Ukraine

Site Status

Instytut nefrologii AMN Ukrainy viddil nefrologii ta dializu

Kyiv, , Ukraine

Site Status

Mykolaivska Oblasna Klinichna Likarnia, Viddilennia Gemodializu

Mykolayiv, , Ukraine

Site Status

Ternopilska Oblasna Klinichna Likarnia, Viddilennia Nefrologii ta Gemodializu

Ternopil, , Ukraine

Site Status

Oblasna klinikchna likarnia, tsentr transplantologii ta gemodializu

Zaporizhzhya, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Bulgaria France Germany Italy North Macedonia Poland Romania Russia Ukraine

References

Explore related publications, articles, or registry entries linked to this study.

Horl WH, Locatelli F, Haag-Weber M, Ode M, Roth K; Epo-PASS study group. Prospective multicenter study of HX575 (biosimilar epoetin-alpha) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl. Clin Nephrol. 2012 Jul;78(1):24-32. doi: 10.5414/cn107440.

Reference Type DERIVED
PMID: 22732334 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2006-66-INJ-14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.